NECTAR LIFESCIENCES LTD.

Company Profile

NECTAR LIFESCIENCES LTD. had its IPO on under the ticker symbol NECLIFE.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. NECTAR LIFESCIENCES LTD. has a staff strength of 0 employees.

Stock update

Shares of NECTAR LIFESCIENCES LTD. opened at ₹26.42 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹24.96 - ₹26.65, and closed at ₹25.09.

This is a -4.82% slip from the previous day's closing price.

A total volume of 72,671 shares were traded at the close of the day’s session.

In the last one week, shares of NECTAR LIFESCIENCES LTD. have slipped by -6.69%.

NECTAR LIFESCIENCES LTD.'s Key Ratios

NECTAR LIFESCIENCES LTD. has a market cap of ₹4.84 billion, indicating a price to book ratio of 0.4823 and a price to sales ratio of 0.2983.

In the last 12-months NECTAR LIFESCIENCES LTD.’s revenue was ₹15.25 billion with a gross profit of ₹3.65 billion and an EBITDA of ₹539.47 million. The EBITDA ratio measures NECTAR LIFESCIENCES LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, NECTAR LIFESCIENCES LTD.’s operating margin was -0.34% while its return on assets stood at -0.14% with a return of equity of -2.25%.

In Q1, NECTAR LIFESCIENCES LTD.’s quarterly earnings growth was a negative -69.2% while revenue growth was a negative 18.4%.

NECTAR LIFESCIENCES LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at ₹-1.08 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into NECTAR LIFESCIENCES LTD.’s profitability.

NECTAR LIFESCIENCES LTD. stock is trading at a EV to sales ratio of 0.6568 and a EV to EBITDA ratio of 8.4231. Its price to sales ratio in the trailing 12-months stood at 0.2983.

NECTAR LIFESCIENCES LTD. stock pays annual dividends of ₹0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹21.89 billion

Total Liabilities

₹8.91 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

NECTAR LIFESCIENCES LTD. ended 2024 with ₹21.89 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹21.89 billion while shareholder equity stood at ₹10.65 billion.

NECTAR LIFESCIENCES LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹8.91 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0.00 in goodwill. Its cash balance stood at ₹175.80 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹2.26 billion.

NECTAR LIFESCIENCES LTD.’s total current assets stands at ₹12.31 billion while long-term investments were ₹0 and short-term investments were ₹420.73 million. Its net receivables were ₹2.80 billion compared to accounts payable of ₹3.19 billion and inventory worth ₹6.73 billion.

In 2024, NECTAR LIFESCIENCES LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, NECTAR LIFESCIENCES LTD. paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹25.09

52-Week High

₹30.55

52-Week Low

₹14.36

Analyst Target Price

₹

NECTAR LIFESCIENCES LTD. stock is currently trading at ₹25.09 per share. It touched a 52-week high of ₹30.55 and a 52-week low of ₹30.55. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹24.37 and 200-day moving average was ₹20.54 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 5704.1% of the company’s stock are held by insiders while 0% are held by institutions.